Section Arrow
CRGX.NASDAQ
- CARGO Therapeutics
Quotes are at least 15-min delayed:2024/05/15 22:18 EDT
Last
 20.99
+1.29 (+6.55%)
Day High 
22.515 
Prev. Close
19.7 
1-M High
22.125 
Volume 
166.77K 
Bid
20.1
Ask
24.42
Day Low
19.975 
Open
20 
1-M Low
18.25 
Market Cap 
775.56M 
Currency USD 
P/E -- 
%Yield
10-SMA 19.97 
20-SMA 19.47 
50-SMA 22.61 
52-W High 33.92 
52-W Low 13.14 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-16.53/-5.50
Enterprise Value
801.83M
Balance Sheet
Book Value Per Share
10.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/15 22:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.